Clinical Study of U32 in Patients With Acute Myeloid Leukemia

Clinical trial NCT07036250 · RECRUITING

Trial details

NCT number: NCT07036250
Sponsor: Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia

Start date: 2025-07-03
Primary completion: 2027-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.